24 Jun 2016 15:41
Â
Â
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Â
Director /PDMR Shareholding
Â
EKF Diagnostics Holdings plc (AIM: EKF) announces that on 23 June 2016, the Company was notified that Harwood Capital LLP ("Harwood") acquired 2,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.
Â
Following the above transaction, which was completed on 23 June 2016 at a price of 11.75 pence per share, NAIT's interest is now in 72,428,103 Ordinary Shares, representing 15.60% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.
Â
The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 112,428,103 Ordinary Shares, representing 24.22% of the Company's issued share capital.
Â
Â
EKF Diagnostics Holdings plc | Tel: 029 2071 0570 | |
Julian Baines, CEOÂ | Â | |
Richard Evans, FD & COO | Â | |
 |  | |
Panmure Gordon (UK) Limited | Tel: 020 7886 2500 | |
Paul Fincham | Â | |
Peter Steel | Â | |
 |  | |
Walbrook PRÂ Limited | Tel: 020 7933 8780 or ekf@walbrookpr.com | |
Paul McManus | Mob: 07980 541 893 | |
Lianne Cawthorne | Mob: 07584 391 303 | |
 |  |  |
Â
Â